ORBIMED ADVISORS LLC Q1 2023 Filing

Filed May 15, 2023

Portfolio Value

$5.1T

Holdings

116

Report Date

Q1 2023

Filing Type

13F-HR

All Holdings (116 positions)

#StockSharesValue% PortfolioType
101
VIGLVIGIL NEUROSCIENCE INC
448,891$4.4B0.09%
102
SRRKSCHOLAR ROCK HLDG CORP
515,000$4.1B0.08%
103
NXTCNEXTCURE INC
2,711,013$4.0B0.08%
104
SYNLOGIC INC
6,029,995$3.8B0.07%
105
CMMBCHEMOMAB THERAPEUTICS LTD
2,241,274$3.6B0.07%
106
EPIEURESSA PHARMA INC
1,198,337$3.6B0.07%
107
TARAPROTARA THERAPEUTICS INC
793,558$2.5B0.05%
108
BOLT1EURBOLT BIOTHERAPEUTICS INC
1,541,000$2.1B0.04%
109
AFIBACUTUS MED INC
2,648,386$2.0B0.04%
110
RVNCEURREVANCE THERAPEUTICS INC
50,000$1.6B0.03%
111
HRTXHERON THERAPEUTICS INC
802,700$1.2B0.02%
112
NKTREURNEKTAR THERAPEUTICS
1,579,059$1.1B0.02%Call
113
PHGEBIOMX INC
3,161,489$964.3M0.02%
114
SINGULAR GENOMICS SYSTEMS IN
540,697$654.2M0.01%
115
ALTALTIMMUNE INC
150,600$635.5M0.01%Call
116
AGLEUSDAEGLEA BIOTHERAPEUTICS INC
1,797,221$521.2M0.01%
117
HARPOON THERAPEUTICS INC
621,218$462.3M0.01%
PreviousPage 2 of 2